Cargando…

Bacterial endocarditis following COVID-19 infection: two case reports

BACKGROUND: COVID-19, an emerging disease raised as a pandemic, urgently needed treatment choices. Some options have been confirmed as lifesaving treatments, but long-term complications must be clearly illustrated. Bacterial endocarditis is a less frequent disease among patients infected with SARS_C...

Descripción completa

Detalles Bibliográficos
Autores principales: Barahimi, Elham, Defaee, Sahar, Shokraei, Rahele, Sheybani-Arani, MohammadHosein, Salimi Asl, Ali, Ghaem, Hossein Montazer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273726/
https://www.ncbi.nlm.nih.gov/pubmed/37322551
http://dx.doi.org/10.1186/s13256-023-03970-6
_version_ 1785059703908204544
author Barahimi, Elham
Defaee, Sahar
Shokraei, Rahele
Sheybani-Arani, MohammadHosein
Salimi Asl, Ali
Ghaem, Hossein Montazer
author_facet Barahimi, Elham
Defaee, Sahar
Shokraei, Rahele
Sheybani-Arani, MohammadHosein
Salimi Asl, Ali
Ghaem, Hossein Montazer
author_sort Barahimi, Elham
collection PubMed
description BACKGROUND: COVID-19, an emerging disease raised as a pandemic, urgently needed treatment choices. Some options have been confirmed as lifesaving treatments, but long-term complications must be clearly illustrated. Bacterial endocarditis is a less frequent disease among patients infected with SARS_COV_2 compared to other cardiac comorbidities in these patients. This case report discusses bacterial endocarditis as a potential adverse effect after administering tocilizumab, corticosteroids, and COVID-19 infection. CASE PRESENTATION: In the first case, a 51-year-old Iranian female housewife was admitted to the hospital with fever, weakness, and monoarthritis symptoms. The second case is a 63-year-old Iranian woman who is a housewife admitted with weakness, shortness of breath, and extreme sweating. Both cases tested positive for Polymerase chain reaction (PCR) less than one month ago and were treated with tocilizumab and corticosteroid. Both patients were suspected of infective endocarditis. Methicillin-resistant Staphylococcus aureus (MRSA) was detected in the blood cultures of both patients. The diagnosis of endocarditis is confirmed for both cases. Cases are subjected to open-heart surgery, a mechanical valve is placed, and they are treated with medication. In subsequent visits, their condition was reported to be improving. CONCLUSION: Adjacent to cardiovascular inclusion as COVID-19 disease complications, secondary infection taken after the organisation of immunocompromising specialists can result in basic maladies and conditions counting infective endocarditis.
format Online
Article
Text
id pubmed-10273726
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102737262023-06-17 Bacterial endocarditis following COVID-19 infection: two case reports Barahimi, Elham Defaee, Sahar Shokraei, Rahele Sheybani-Arani, MohammadHosein Salimi Asl, Ali Ghaem, Hossein Montazer J Med Case Rep Case Report BACKGROUND: COVID-19, an emerging disease raised as a pandemic, urgently needed treatment choices. Some options have been confirmed as lifesaving treatments, but long-term complications must be clearly illustrated. Bacterial endocarditis is a less frequent disease among patients infected with SARS_COV_2 compared to other cardiac comorbidities in these patients. This case report discusses bacterial endocarditis as a potential adverse effect after administering tocilizumab, corticosteroids, and COVID-19 infection. CASE PRESENTATION: In the first case, a 51-year-old Iranian female housewife was admitted to the hospital with fever, weakness, and monoarthritis symptoms. The second case is a 63-year-old Iranian woman who is a housewife admitted with weakness, shortness of breath, and extreme sweating. Both cases tested positive for Polymerase chain reaction (PCR) less than one month ago and were treated with tocilizumab and corticosteroid. Both patients were suspected of infective endocarditis. Methicillin-resistant Staphylococcus aureus (MRSA) was detected in the blood cultures of both patients. The diagnosis of endocarditis is confirmed for both cases. Cases are subjected to open-heart surgery, a mechanical valve is placed, and they are treated with medication. In subsequent visits, their condition was reported to be improving. CONCLUSION: Adjacent to cardiovascular inclusion as COVID-19 disease complications, secondary infection taken after the organisation of immunocompromising specialists can result in basic maladies and conditions counting infective endocarditis. BioMed Central 2023-06-16 /pmc/articles/PMC10273726/ /pubmed/37322551 http://dx.doi.org/10.1186/s13256-023-03970-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Barahimi, Elham
Defaee, Sahar
Shokraei, Rahele
Sheybani-Arani, MohammadHosein
Salimi Asl, Ali
Ghaem, Hossein Montazer
Bacterial endocarditis following COVID-19 infection: two case reports
title Bacterial endocarditis following COVID-19 infection: two case reports
title_full Bacterial endocarditis following COVID-19 infection: two case reports
title_fullStr Bacterial endocarditis following COVID-19 infection: two case reports
title_full_unstemmed Bacterial endocarditis following COVID-19 infection: two case reports
title_short Bacterial endocarditis following COVID-19 infection: two case reports
title_sort bacterial endocarditis following covid-19 infection: two case reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273726/
https://www.ncbi.nlm.nih.gov/pubmed/37322551
http://dx.doi.org/10.1186/s13256-023-03970-6
work_keys_str_mv AT barahimielham bacterialendocarditisfollowingcovid19infectiontwocasereports
AT defaeesahar bacterialendocarditisfollowingcovid19infectiontwocasereports
AT shokraeirahele bacterialendocarditisfollowingcovid19infectiontwocasereports
AT sheybaniaranimohammadhosein bacterialendocarditisfollowingcovid19infectiontwocasereports
AT salimiaslali bacterialendocarditisfollowingcovid19infectiontwocasereports
AT ghaemhosseinmontazer bacterialendocarditisfollowingcovid19infectiontwocasereports